Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Medipharm Labs Corp
T.LABS
Alternate Symbol(s):
MEDIF
Healthcare
Cannabis
MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes,...
packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. The Company's subsidiary, Harvest Medicine provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:LABS)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
...
Next
(517)
•••
1hot-techwoman
X
View Profile
View Bullboard History
Post by
1hot-techwoman
on Mar 27, 2024 6:41am
Congrats LABS Best Results in 4 Years !! Very Nice $$$$ :)
MediPharm Labs Reports Fourth Quarter and Full Year Results Wednesday, March 27, 2024, 6:30 AM ET Annual Revenue and Adjusted EBITDA Improve by 50% TORONTO, March 27, 2024 /CNW
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Mar 27, 2024 6:30am
New Press Release - MediPharm Labs Reports Fourth Quarter and Full Year Results
Annual Revenue and Adjusted EBITDA Improve by 50%TORONTO, March 27, 2024 /PRNewswire/ - MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company specialized in precision-based cannabinoids, today announced its financial...
read article.
Strong Q1 and Muscular Q2 Outlook for Cannabis Edibles Leader
posted May 26, 2024 9:00am by
Indiva Ltd
-
|
Gross revenue Q1 was $10.6 million, a 2.6% increase YOY as the company replaced over 50% of its net revenue from Wana’s shift to contract manufacturing and a regulatory change with its own core brands, namely Pearls gummies. Post Q1, April 2024 was a record month for net revenue, with growth driven by continued strength in Pearls, revenue from No Future gummies and Indiva Blips ...read more
(81)
•••
Solid1
X
View Profile
View Bullboard History
Comment by
Solid1
on Mar 27, 2024 4:32am
RE:RE:LABS Is not Special
That's right, MdJ! Medipharm Labs has come a long way, but is better positioned today than ever before. Over the last few years, we have seen this company transform into a pharmaceutical company
...more
(18)
•••
Lvlchange
X
View Profile
View Bullboard History
Comment by
Lvlchange
on Mar 26, 2024 11:57pm
RE:RE:LABS Is not Special
I'm just concerned of the ankle biters coming after our lunch that we haven't eaten... imagine the amount of wannabes that are coming out soon.
(552)
•••
mdjbrown
X
View Profile
View Bullboard History
Comment by
mdjbrown
on Mar 26, 2024 11:43pm
RE:LABS Is not Special
Difference being Lvl is the folks at Medipharm spent the last 5 years laying the long and tricky regulatory groundwork in several parts of the world, and it is slowly starting to pay off as they are
...more
(18)
•••
Lvlchange
X
View Profile
View Bullboard History
Post by
Lvlchange
on Mar 26, 2024 10:53pm
LABS Is not Special
There is too much to say, we don't have a monopoly, too many on this board seem to think so. GMP means nothing and what about all the overseas companies that can't wait to to business in
...more
(18)
•••
Lvlchange
X
View Profile
View Bullboard History
Post by
Lvlchange
on Mar 26, 2024 10:47pm
Hockey Playoffs-LABS Playoffs
I'm a hockey guy... Lets say you are 8 points (4 games) out of a playoff spot. Between you and the last team in a playoff spot there are 3 more teams. you say ohhhhhh geeeee if
...more
(603)
•••
subaru1i
X
View Profile
View Bullboard History
Post by
subaru1i
on Mar 26, 2024 9:03pm
Can cannbinoid veterinary pharmecutical kill avian bird flu?
3 states in the U.S. have dairy milk herds infected with the highly contagious avian bird flu but don't worry, gov't saying, don't worry, "low risk" of transfer to humans but is
...more
(603)
•••
subaru1i
X
View Profile
View Bullboard History
Comment by
subaru1i
on Mar 26, 2024 8:55pm
RE:RE:RE:Tough to argue STADA's place in the European Pharma game.
Contract development and manufacturing organization (CDMO) Norbitec biotech, a joint venture between generics firm Stada and biologics firm Nordmark, will supply Pfizer with Retacrit from its site in
...more
(552)
•••
mdjbrown
X
View Profile
View Bullboard History
Comment by
mdjbrown
on Mar 26, 2024 5:14pm
RE:RE:Tough to argue STADA's place in the European Pharma game.
Agree 100% okgonow Lets hope they have a similiar STADA type relationship behind the scenes in both Brazil and the USA. Bout time some of these mystery partners are revealed by the folks at
...more
(547)
•••
okgonow
X
View Profile
View Bullboard History
Comment by
okgonow
on Mar 26, 2024 5:05pm
RE:Tough to argue STADA's place in the European Pharma game.
that just shows you how long great things take to come to fruition, the partnership was set up over 3 years ago and i am sure that these guys have been working hard for what is about to happen in
...more
(552)
•••
mdjbrown
X
View Profile
View Bullboard History
Post by
mdjbrown
on Mar 26, 2024 4:52pm
Tough to argue STADA's place in the European Pharma game.
Lets hope it translates to bigger revenue streams for Medipharm after the 1st. https://www.forbes.com/sites/javierhasse/2020/10/05/73-billion-pharma-company-gets-into-the-cannabis-game/?sh
...more
(547)
•••
okgonow
X
View Profile
View Bullboard History
Comment by
okgonow
on Mar 26, 2024 4:49pm
RE:RE:RE:My "intrinsic unlocked book value" is +$20
i sure hope we get that guidance thats more important than anything!
(48)
•••
QContinuum1
X
View Profile
View Bullboard History
Comment by
QContinuum1
on Mar 26, 2024 4:35pm
RE:RE:My "intrinsic unlocked book value" is +$20
May well be more than 0.20c by Q2 provided that even just one of the larger irons in the fire hit. I think 0.20c is will say Germany spooling up and a little jingle from Brazil. If a
...more
Prev
...
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >